DK0716605T3 - Blokering af aflejring af kim på humane celler - Google Patents

Blokering af aflejring af kim på humane celler

Info

Publication number
DK0716605T3
DK0716605T3 DK94927587T DK94927587T DK0716605T3 DK 0716605 T3 DK0716605 T3 DK 0716605T3 DK 94927587 T DK94927587 T DK 94927587T DK 94927587 T DK94927587 T DK 94927587T DK 0716605 T3 DK0716605 T3 DK 0716605T3
Authority
DK
Denmark
Prior art keywords
germ
blockage
deposition
human cells
degree
Prior art date
Application number
DK94927587T
Other languages
English (en)
Inventor
Josef Peter Prof Guggenbichler
Johann Prof Dr Jurenitsch
Bettignies-Dutz Andreas Dr De
Peter Meissner
Original Assignee
Josef Peter Prof Guggenbichler
Johann Prof Dr Jurenitsch
Bettignies Dutz Andreas Dr De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Josef Peter Prof Guggenbichler, Johann Prof Dr Jurenitsch, Bettignies Dutz Andreas Dr De filed Critical Josef Peter Prof Guggenbichler
Application granted granted Critical
Publication of DK0716605T3 publication Critical patent/DK0716605T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94927587T 1993-09-10 1994-09-08 Blokering af aflejring af kim på humane celler DK0716605T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4330773A DE4330773A1 (de) 1993-09-10 1993-09-10 Blockierung der Anlagerung von Keimen an menschliche Zellen
PCT/EP1994/003006 WO1995007084A1 (de) 1993-09-10 1994-09-08 Blockierung der anlagerung von keimen an menschliche zellen

Publications (1)

Publication Number Publication Date
DK0716605T3 true DK0716605T3 (da) 1999-08-16

Family

ID=6497409

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94927587T DK0716605T3 (da) 1993-09-10 1994-09-08 Blokering af aflejring af kim på humane celler

Country Status (16)

Country Link
US (1) US5683991A (da)
EP (1) EP0716605B1 (da)
JP (1) JP3798425B2 (da)
AT (1) ATE174222T1 (da)
AU (1) AU679262B2 (da)
CA (1) CA2171197A1 (da)
CZ (1) CZ288050B6 (da)
DE (2) DE4330773A1 (da)
DK (1) DK0716605T3 (da)
ES (1) ES2127940T3 (da)
GR (1) GR3029619T3 (da)
HU (1) HU223043B1 (da)
PL (1) PL313393A1 (da)
RU (1) RU96107098A (da)
SK (1) SK282305B6 (da)
WO (1) WO1995007084A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
US5951965A (en) * 1998-08-28 1999-09-14 Colgate Palmolive Company Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition
AU730929B2 (en) * 1999-07-06 2001-03-22 Nestec S.A. Composition and method for prolonging the useful life of enteral feeding tubes
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
DE10061574A1 (de) * 2000-12-11 2002-06-13 Josef Peter Guggenbichler Blockierung der Anlagerung von Keimen bei Vögeln
FR2831819B1 (fr) * 2001-11-08 2004-09-03 Rocher Yves Biolog Vegetale Utilisation d'oligosaccharides dans des compositions cosmetiques ou dermatologiques pour stimuler l'adhesion de keratinocytes sur les proteines majeures de la jonction dermo-epidermique
FR2852242B1 (fr) * 2003-03-13 2007-09-14 Utilisation d'oligogalacturonides en cosmetique ou pour la preparation d'une composition dermatologique ou pharmaceutique
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US8110215B2 (en) * 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
MX2007002080A (es) * 2004-08-18 2007-07-19 Biolog Health Solutions Pty Lt Composiciones de plantas medicinales para la prevencion o tratamiento de incontinencia urinaria y vejiga hiperactiva.
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) * 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
CA2706637C (en) 2007-11-27 2016-11-29 Algipharma Ipr As Use of alginate oligomers in combating biofilms
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
PT2437783E (pt) 2009-06-03 2014-01-22 Algipharma As Tratamento de acinetobacter com oligómeros de alginato e antibióticos
GB0909529D0 (en) * 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
WO2011060474A1 (de) 2009-11-20 2011-05-26 Erber Aktiengesellschaft Verfahren zur herstellung eines futtermittelzusatzes sowie futtermittelzusatz
US20150080826A1 (en) * 2013-08-28 2015-03-19 The Procter & Gamble Company Substrate comprising oligogalacturonides and disposable absorbent article comprising the substrate
DE102013022109A1 (de) * 2013-12-27 2015-07-02 Markus Paulmichl Oligo-(2-7)-Glucuronat umfassendes Medikament (zweite medizinische Indikation)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987448A (en) * 1959-12-11 1961-06-06 Oil Seed Products Inc Recovery of galacturonic acid
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation
US4885128A (en) * 1985-07-30 1989-12-05 Janez Megusar Method for improving performance of irradiated structural materials
GB8803157D0 (en) * 1988-02-11 1988-03-09 Nat Res Dev Denture protection
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
EP0481038B1 (en) * 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5523014A (en) * 1994-05-16 1996-06-04 Gojo Industries, Inc. Flowable, pumpable cleaning compositions and method for the preparation thereof

Also Published As

Publication number Publication date
JPH09502195A (ja) 1997-03-04
US5683991A (en) 1997-11-04
SK282305B6 (sk) 2002-01-07
AU7695694A (en) 1995-03-27
DE59407457D1 (de) 1999-01-21
HU9600602D0 (en) 1996-05-28
CZ288050B6 (cs) 2001-04-11
GR3029619T3 (en) 1999-06-30
ATE174222T1 (de) 1998-12-15
RU96107098A (ru) 1998-07-27
AU679262B2 (en) 1997-06-26
CZ70896A3 (en) 1996-10-16
EP0716605B1 (de) 1998-12-09
CA2171197A1 (en) 1995-03-16
HU223043B1 (hu) 2004-03-01
WO1995007084A1 (de) 1995-03-16
DE4330773A1 (de) 1995-03-16
JP3798425B2 (ja) 2006-07-19
HUT74431A (en) 1996-12-30
EP0716605A1 (de) 1996-06-19
ES2127940T3 (es) 1999-05-01
SK32996A3 (en) 1997-03-05
PL313393A1 (en) 1996-06-24

Similar Documents

Publication Publication Date Title
DK0716605T3 (da) Blokering af aflejring af kim på humane celler
BR9914499A (pt) Agentes de proteção de colheitas ambientalmente benignas
FI970067A0 (fi) 2-/(dihydro)pyratsolyyli-3'-oksimetyleeni/-anilidit tuholaistentorjunta-aineina ja fungisideina
ITRM910292A0 (it) Procedimento per la preparazione di elastomeri mediante l'impiego di polioli o poliammine ad elevato peso molecolare.
NO902834D0 (no) Regulering av mikrobiell vekst med lantibiotiske/lysosymformuleringer.
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
ATE168682T1 (de) Herbizide substituierte 1-phenyl-oder 1-pyridinyl-benzotriazole
BR9809746A (pt) Compostos de éteres oxìmicos, seu uso e intermediários para preparações dos mesmos.
ITTO940823A0 (it) Composizione per regolare la crescita di insetti.
IT9022010A0 (it) Procedimento per la utilizzazione dirifiuti organici per la produzionedi biogas e di prodotti per l'agricoltura.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
RU95114858A (ru) Новый пептидный фрагмент, обладающий биологической активностью инсулина
AUPO410696A0 (en) Inactivation of viruses by incubation with caprylate
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
Highsmith et al. Clinical microbiology newsletter.
RU93020831A (ru) Зубной эликсир
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante